Andromeda Metals Limited (ADN.AX)
AUD 0.01
(0.0%)
AUD 0.01
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 490.81 Thousand | 424.72 Thousand | 191.02 Thousand | 93.22 Thousand | 37.85 Thousand | 3873.00 |
| Gross Profit | -490.81 Thousand | -424.72 Thousand | -191.02 Thousand | -93.22 Thousand | -37.85 Thousand | -3873.00 |
| Operating Expenses | 7.43 Million | 10.29 Million | 8.33 Million | 6.1 Million | 3.69 Million | 920.64 Thousand |
| Selling, General and Administrative Expenses | 6.61 Million | 7.45 Million | 7.48 Million | 6.1 Million | 3.69 Million | 920.64 Thousand |
| Research and Development Expenses | 821.12 Thousand | 2.83 Million | 846.46 Thousand | - | - | - |
| Other Expenses | - | 1.54 Million | 413.21 Thousand | 52.82 Thousand | 748.5 Thousand | 486.00 |
| Cost and Expenses | 7.43 Million | 10.71 Million | 8.52 Million | 6.19 Million | 3.73 Million | 924.52 Thousand |
| Operating Income | -7.43 Million | -10.71 Million | -8.52 Million | -6.19 Million | -3.73 Million | -924.52 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -105.44 Thousand | -1.54 Million | 239.53 Thousand | 7517.00 | 81.97 Thousand | 72.13 Thousand |
| Earnings before Tax | -7.26 Million | -11 Million | -8.49 Million | -6.17 Million | -3.36 Million | -1.04 Million |
| Net Income | -7.26 Million | -9.46 Million | -8.73 Million | -6.44 Million | -3.44 Million | -1.11 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 3.11 Billion | 3.1 Billion | 2.66 Billion | 1.96 Billion | 1.42 Billion | 1.14 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.11 Billion | 3.1 Billion | 2.66 Billion | 1.96 Billion | 1.42 Billion | 1.14 Billion |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -6.44 Million | -10.58 Million | -8.3 Million | -6.07 Million | -3.32 Million | -1.03 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | 424.72 Thousand | - | - |
| Gross Profit | - | - | - | -424.72 Thousand | - | - |
| Operating Expenses | 3360.08 | 4075.38 | 5.56 Million | 10.29 Million | 5.21 Million | 4.77 Million |
| Selling, General and Administrative Expenses | 3067.58 | 3546.75 | 4.64 Million | - | 3.3 Million | 3.93 Million |
| Research and Development Expenses | 292.49 | 528.63 | 923.32 Thousand | - | 1.91 Million | 846.46 Thousand |
| Other Expenses | - | - | - | 1.54 Million | - | - |
| Cost and Expenses | 3360.08 | 4075.38 | 5.56 Million | 10.71 Million | 5.21 Million | 4.77 Million |
| Operating Income | -3360.08 | -4075.38 | -5.56 Million | -10.71 Million | -5.21 Million | -4.77 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 151.60 | -559.48 Thousand | -633.26 Thousand | -1.54 Million | -914.15 Thousand | 4.77 Million |
| Earnings before Tax | -3055.47 | -4213.68 | -5.97 Million | -11 Million | -5.03 Million | -4.78 Million |
| Net Income | -3055.47 | -4213.68 | -5.34 Million | -9.46 Million | -4.11 Million | -4.78 Million |
| Earnings Per Share Basic | - | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | - | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 3.21 Billion | 3 Billion | 3.11 Billion | 3.1 Billion | 3.1 Billion | 2.84 Billion |
| Weighted Average Shares Outstanding (Diluted) | 3.21 Billion | 3 Billion | 3.11 Billion | 3.1 Billion | 3.1 Billion | 2.84 Billion |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -2974.94 | -3473.26 | -4900.78 | - | -4239.54 | -4197.82 |
| Earnings Before Tax Margin | - | - | - | - | - | - |
CLABF
ATOGF
MSTCLTD
HRZ
8119
KLSO